Open an Account
search icon
4
NOTIFICATIONS
Best Algo trading app in India
Bigul

Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 (Listing Regulations')

 Pursuant to the Regulation 30 of the Listing Regulations, we enclose herewith the transcript of the tele conference call with the analysts held on May 18, 2017, to discuss the Company's financial performance for the quarter and the financial year ended March 31, 2017. The aforesaid information will be displayed on the website of the Company in compliance with Regulation 46 of the Listing Regulations.
19-05-2017
Bigul

Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 (Listing Regulations') - Analyst Teleconference

 Pursuant to the Regulation 30 of the Listing Regulations, we hereby inform you that a teleconference has been scheduled with the Analysts on Thursday, May 18, 2017, at 4.00 p.m. to discuss the Company's financial performance for the quarter and the financial year ended March 31, 2017. The details of the teleconference are uploaded on the website: www.pfizerindia.com.
17-05-2017
Bigul

Annual report for Pfizer Ltd. for FY-2017
08-05-2017

Q4 result update: Pfizer's net profit falls sharply in fourth quarter

 Pharma firm Pfizer Ltd has reported a steep 21.98% dip in standalone net profits, a decline to Rs 68.04 crores for its Q4 this financial year. The total income for the quarter came in at Rs. 481.9 crore, 14.7% down compared to the same quarter last year. The company's EBITDA margin in Q4 fell by 243 bps. The company however recorded net profit growth for the entire year, up 10.4% in FY17 compared to FY16. The board of directors of the company has recommended a normal dividend of Rs 15 per equity share of Rs 10 each and a special dividend of Rs 5 per share due to exceptional income.
07-05-2017

Pfizer Q4 net profit falls 22% to Rs68 crore

 Pfizer Q4 total income stood at Rs481.97 crore as against Rs563.57 crore in the year-ago period
06-05-2017
Bigul

Press Release

 Please find enclosed press release for the financial results for the quarter and financial year ended March 31, 2017.
06-05-2017
Bigul

Updates

 Pursuant to regulation 30(2) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby inform you that the Board of Directors of the Company at their Meeting held today have re-appointed Mr. Vivek Dhariwal (DIN: 02826679) as an Whole-time Director designated as Executive Director, Technical Operations with effect from May 21, 2017 for a term of 5 years. The re-appointment of Mr. Vivek Dhariwal will be subject to the...
06-05-2017
Bigul

Updates

 This is to inform you that the Statutory Auditors B S R & Co. LLP would be completing their maximum term permitted under Section 139 of the Companies Act, 2013 and the Rules made thereunder at the ensuing Annual General Meeting of the Company. In view of the same, the Board of Directors of the Company at their meeting held on May 6, 2017, have recommended, the appointment of Walker Chandiok & Co LLP, Chartered Accountants (Firm...
06-05-2017
Bigul

Board recommends Dividend

 Pfizer Ltd has informed BSE that the Board of Directors of the Company at its meeting held on May 06, 2017, inter alia, has recommended a normal divided of 150% ( Rs. 15 per equity share of Rs. 10 each) and a special dividend of 50% (Rs. 5 per equity share of Rs. 10 each) on account of exceptional income during the year, aggregating to total dividend of 200% ( Rs. 20 per equity share of Rs. 10 each) for the financial year ended March 31, 2017. The...
06-05-2017
Bigul

Pfizer Limited Audited Financial Results For Quarter And Financial Year Ended March 31, 2017

 Pursuant to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we submit herewith audited financial results for the quarter and financial year ended March 31, 2017, which were approved by the Board of Directors of the Company at its Meeting held today, that commenced at 3.30 p.m. and concluded at 5.30 p.m. Further, please be informed that The Board of Directors of the Company has recommended a normal...
06-05-2017
Next Page
Close

Let's Open Free Demat Account